drugset / Trial / NCT00986427

Restasis for Treatment of Brittle Nails

NCT00986427 ↗

Phase 2 Completed 24 enrolled Julian M. Mackay-Wiggan Allergan · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This purpose of this study is to assess the safety and effectiveness of Restasis® ophthalmic emulsion versus emulsion alone( Refresh Dry Eye therapy) both for the treatment of brittle nails and for the enhancement of normal nail growth and texture. The investigators think that daily application of Restasis® to nails and nail beds in patients with brittle nails will enhance nail growth and improve nail texture in both affected and unaffected nails.

Timeline

Start
2009-07
Primary completion
2010-07
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 0.05 % Topical

Indications

No indication recorded.